XAI meets Biology: A Comprehensive Review of Explainable AI in Bioinformatics Applications
Authors:
Zhongliang Zhou,
Mengxuan Hu,
Mariah Salcedo,
Nathan Gravel,
Wayland Yeung,
Aarya Venkat,
Dongliang Guo,
Jielu Zhang,
Natarajan Kannan,
Sheng Li
Abstract:
Artificial intelligence (AI), particularly machine learning and deep learning models, has significantly impacted bioinformatics research by offering powerful tools for analyzing complex biological data. However, the lack of interpretability and transparency of these models presents challenges in leveraging these models for deeper biological insights and for generating testable hypotheses. Explaina…
▽ More
Artificial intelligence (AI), particularly machine learning and deep learning models, has significantly impacted bioinformatics research by offering powerful tools for analyzing complex biological data. However, the lack of interpretability and transparency of these models presents challenges in leveraging these models for deeper biological insights and for generating testable hypotheses. Explainable AI (XAI) has emerged as a promising solution to enhance the transparency and interpretability of AI models in bioinformatics. This review provides a comprehensive analysis of various XAI techniques and their applications across various bioinformatics domains including DNA, RNA, and protein sequence analysis, structural analysis, gene expression and genome analysis, and bioimaging analysis. We introduce the most pertinent machine learning and XAI methods, then discuss their diverse applications and address the current limitations of available XAI tools. By offering insights into XAI's potential and challenges, this review aims to facilitate its practical implementation in bioinformatics research and help researchers navigate the landscape of XAI tools.
△ Less
Submitted 10 December, 2023;
originally announced December 2023.
Prediction of Blood Lactate Values in Critically Ill Patients: A Retrospective Multi-center Cohort Study
Authors:
Behrooz Mamandipoor,
Wesley Yeung,
Louis Agha-Mir-Salim,
David J. Stone,
Venet Osmani,
Leo Anthony Celi
Abstract:
Purpose. Elevations in initially obtained serum lactate levels are strong predictors of mortality in critically ill patients. Identifying patients whose serum lactate levels are more likely to increase can alert physicians to intensify care and guide them in the frequency of tending the blood test. We investigate whether machine learning models can predict subsequent serum lactate changes.
Metho…
▽ More
Purpose. Elevations in initially obtained serum lactate levels are strong predictors of mortality in critically ill patients. Identifying patients whose serum lactate levels are more likely to increase can alert physicians to intensify care and guide them in the frequency of tending the blood test. We investigate whether machine learning models can predict subsequent serum lactate changes.
Methods. We investigated serum lactate change prediction using the MIMIC-III and eICU-CRD datasets in internal as well as external validation of the eICU cohort on the MIMIC-III cohort. Three subgroups were defined based on the initial lactate levels: i) normal group (<2 mmol/L), ii) mild group (2-4 mmol/L), and iii) severe group (>4 mmol/L). Outcomes were defined based on increase or decrease of serum lactate levels between the groups. We also performed sensitivity analysis by defining the outcome as lactate change of >10% and furthermore investigated the influence of the time interval between subsequent lactate measurements on predictive performance.
Results. The LSTM models were able to predict deterioration of serum lactate values of MIMIC-III patients with an AUC of 0.77 (95% CI 0.762-0.771) for the normal group, 0.77 (95% CI 0.768-0.772) for the mild group, and 0.85 (95% CI 0.840-0.851) for the severe group, with a slightly lower performance in the external validation.
Conclusion. The LSTM demonstrated good discrimination of patients who had deterioration in serum lactate levels. Clinical studies are needed to evaluate whether utilization of a clinical decision support tool based on these results could positively impact decision-making and patient outcomes.
△ Less
Submitted 7 July, 2021;
originally announced July 2021.
